Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Biol Macromol ; 139: 1028-1034, 2019 Oct 15.
Article in English | MEDLINE | ID: mdl-31404600

ABSTRACT

We report cloning and expressing of recombinant human VEGF-A165, fused at the N-terminal with Hydrophobin II (HFBII) from Trichoderma reseei, in yeast Pichia pastoris. We validated the construct using SDS-PAGE and ELISA against VEGF-A165 and efficiently performed protein purification and enrichment based on HFBII counterpart and using an aqueous two-phase system (ATPS) with nonionic surfactant X-114. We studied the effects of various culture medium additives and interaction effects of positive factors to increase the recombinant HFBII-VEGF-A165 production. Supplementing the Pichia pastoris cell culture medium with Mg2+, Polysorbate 20 (PS 20), and 4-phenylbutyrate (PBA) improved the expression of the chimeric protein. Orthogonal experiments showed that the optimal condition to achieve maximal HFBII-VEGF-A165 production was with the addition of PBA, PS 20, and MgSO4. Under this condition, the production of the target protein was 4.5 times more than that in the medium without the additives. Overall, our approach to produce chimeric HFBII-VEGF-A165 and selectively capture it in ATPS is promising for large-scale protein production without laborious downstream processing.


Subject(s)
Fungal Proteins/genetics , Fungal Proteins/isolation & purification , Pichia/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Vascular Endothelial Growth Factor A/genetics , Antibodies, Immobilized/chemistry , Antibodies, Immobilized/metabolism , Cell Proliferation , Fungal Proteins/metabolism , Gene Expression , Pichia/cytology , Ranibizumab/chemistry , Ranibizumab/metabolism , Trichoderma/genetics
SELECTION OF CITATIONS
SEARCH DETAIL